255 related articles for article (PubMed ID: 22618473)
1. [Application of MR/PET in oncologic imaging].
Schwenzer NF; Pfannenberg C; Reischl G; Werner MK; Schmidt H
Rofo; 2012 Sep; 184(9):780-7. PubMed ID: 22618473
[TBL] [Abstract][Full Text] [Related]
2. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
3. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
Drzezga A; Souvatzoglou M; Eiber M; Beer AJ; Fürst S; Martinez-Möller A; Nekolla SG; Ziegler S; Ganter C; Rummeny EJ; Schwaiger M
J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous reconstruction of activity and attenuation for PET/MR.
Salomon A; Goedicke A; Schweizer B; Aach T; Schulz V
IEEE Trans Med Imaging; 2011 Mar; 30(3):804-13. PubMed ID: 21118768
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients--current state of image quality.
Schwenzer NF; Stegger L; Bisdas S; Schraml C; Kolb A; Boss A; Müller M; Reimold M; Ernemann U; Claussen CD; Pfannenberg C; Schmidt H
Eur J Radiol; 2012 Nov; 81(11):3472-8. PubMed ID: 22260898
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
Pauls S; Schmidt SA; Juchems MS; Klass O; Luster M; Reske SN; Brambs HJ; Feuerlein S
Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700
[TBL] [Abstract][Full Text] [Related]
7. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG
J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
[TBL] [Abstract][Full Text] [Related]
8. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the attenuation properties of MR equipment for its use in a whole-body PET/MR scanner.
Delso G; Martinez-Möller A; Bundschuh RA; Ladebeck R; Candidus Y; Faul D; Ziegler SI
Phys Med Biol; 2010 Aug; 55(15):4361-74. PubMed ID: 20647598
[TBL] [Abstract][Full Text] [Related]
10. Musculoskeletal applications of PET/MR.
Lee IS; Jin YH; Hong SH; Yang SO
Semin Musculoskelet Radiol; 2014 Apr; 18(2):203-16. PubMed ID: 24715451
[TBL] [Abstract][Full Text] [Related]
11. Diffusion tensor imaging in a human PET/MR hybrid system.
Boss A; Kolb A; Hofmann M; Bisdas S; Nägele T; Ernemann U; Stegger L; Rossi C; Schlemmer HP; Pfannenberg C; Reimold M; Claussen CD; Pichler BJ; Klose U
Invest Radiol; 2010 May; 45(5):270-4. PubMed ID: 20351651
[TBL] [Abstract][Full Text] [Related]
12. Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis.
Buchbender C; Heusner TA; Lauenstein TC; Bockisch A; Antoch G
J Nucl Med; 2012 Jun; 53(6):928-38. PubMed ID: 22582048
[TBL] [Abstract][Full Text] [Related]
13. [Recent advances in MR imaging for cancer diagnosis].
Sagiyama K; Watanabe Y; Nishie A; Kamei R; Togao O; Hiwatashi A; Kawanami S; Honda H
Gan To Kagaku Ryoho; 2015 Mar; 42(3):257-60. PubMed ID: 25812492
[TBL] [Abstract][Full Text] [Related]
14. Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potential applications.
Kwee TC; Takahara T; Ochiai R; Koh DM; Ohno Y; Nakanishi K; Niwa T; Chenevert TL; Luijten PR; Alavi A
J Nucl Med; 2010 Oct; 51(10):1549-58. PubMed ID: 20847177
[TBL] [Abstract][Full Text] [Related]
15. MR-Based PET attenuation correction for PET/MR imaging.
Bezrukov I; Mantlik F; Schmidt H; Schölkopf B; Pichler BJ
Semin Nucl Med; 2013 Jan; 43(1):45-59. PubMed ID: 23178088
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography/magnetic resonance imaging evaluation of lung cancer: current status and future prospects.
Yoon SH; Goo JM; Lee SM; Park CM; Seo HJ; Cheon GJ
J Thorac Imaging; 2014 Jan; 29(1):4-16. PubMed ID: 24296699
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
[TBL] [Abstract][Full Text] [Related]
18. A comparison of MR-based attenuation correction in PET versus SPECT.
Marshall HR; Stodilka RZ; Theberge J; Sabondjian E; Legros A; Deans L; Sykes JM; Thompson RT; Prato FS
Phys Med Biol; 2011 Jul; 56(14):4613-29. PubMed ID: 21725141
[TBL] [Abstract][Full Text] [Related]
19. Multimodal imaging approaches: PET/CT and PET/MRI.
Pichler BJ; Judenhofer MS; Pfannenberg C
Handb Exp Pharmacol; 2008; (185 Pt 1):109-32. PubMed ID: 18626801
[TBL] [Abstract][Full Text] [Related]
20. Whole-body MRI for the staging and follow-up of patients with metastasis.
Schmidt GP; Reiser MF; Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
